Jiazhe Liu

708 total citations
24 papers, 469 citations indexed

About

Jiazhe Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jiazhe Liu has authored 24 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Jiazhe Liu's work include Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Jiazhe Liu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Jiazhe Liu collaborates with scholars based in China, Singapore and Taiwan. Jiazhe Liu's co-authors include Weiyan Liu, Anwei Mao, Jingfeng Lu, Junbin Ding, Hongchang Li, Xinyu Huang, Guanggai Xia, Hongcheng Wang, Xiu−Yan Huang and Jianfa Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Jiazhe Liu

24 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiazhe Liu China 13 315 191 108 49 37 24 469
Aiguang Zhao China 13 283 0.9× 167 0.9× 93 0.9× 80 1.6× 49 1.3× 33 480
Qihua Xu China 13 281 0.9× 142 0.7× 72 0.7× 39 0.8× 25 0.7× 38 577
Jiao Xue China 11 333 1.1× 142 0.7× 83 0.8× 62 1.3× 28 0.8× 24 519
Aiping Shi China 14 207 0.7× 110 0.6× 146 1.4× 38 0.8× 32 0.9× 37 451
Peng Xiao China 14 228 0.7× 135 0.7× 83 0.8× 48 1.0× 51 1.4× 25 401
Ziping Zhang China 10 244 0.8× 132 0.7× 96 0.9× 36 0.7× 52 1.4× 23 391
Hongru Kong China 13 334 1.1× 277 1.5× 74 0.7× 33 0.7× 87 2.4× 24 535
Caiyong Lai China 13 259 0.8× 118 0.6× 59 0.5× 68 1.4× 40 1.1× 37 427
Shengjie Dai China 12 206 0.7× 105 0.5× 103 1.0× 31 0.6× 44 1.2× 31 437

Countries citing papers authored by Jiazhe Liu

Since Specialization
Citations

This map shows the geographic impact of Jiazhe Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiazhe Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiazhe Liu more than expected).

Fields of papers citing papers by Jiazhe Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiazhe Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiazhe Liu. The network helps show where Jiazhe Liu may publish in the future.

Co-authorship network of co-authors of Jiazhe Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiazhe Liu. A scholar is included among the top collaborators of Jiazhe Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiazhe Liu. Jiazhe Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yubo, Jiazhe Liu, Pu Chen, et al.. (2025). Alkyl chain engineering of ionic AIE molecules for developing superior self-adjuvanted nanovaccines in cancer immunotherapy. Chemical Engineering Journal. 506. 159979–159979. 1 indexed citations
2.
Liu, Jiazhe, Ruoyao Zhang, Pu Chen, et al.. (2025). Highly Efficient and Universal Degradation of PD‐L1 via Mitochondrial Oxidative Stress Evoked by Cationic AIE‐Active Photosensitizers for Cancer Immunotherapy. Advanced Functional Materials. 35(7). 4 indexed citations
3.
Mao, Anwei, et al.. (2023). Proteomics Analysis of Polyphyllin D-Treated Triple-Negative Breast Cancer Cells Reveal the Anticancer Mechanisms of Polyphyllin D. Applied Biochemistry and Biotechnology. 196(6). 3148–3161. 1 indexed citations
4.
Cong, Shan, Hongchang Li, Jiazhe Liu, et al.. (2023). Integration of scRNA and bulk RNA-sequence to construct the 5-gene molecular prognostic model based on the heterogeneity of thyroid carcinoma endothelial cell. Acta Biochimica et Biophysica Sinica. 56(2). 255–269. 3 indexed citations
6.
Zeng, Ming, et al.. (2022). An Improved Object Detection Algorithm for Assembly Line Garbage Sorting. 2022 41st Chinese Control Conference (CCC). 7118–7123. 1 indexed citations
7.
Wang, Hongcheng, Jianfa Wang, Jiazhe Liu, et al.. (2022). Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c-Myc-dependent manner. Cellular Signalling. 93. 110282–110282. 10 indexed citations
8.
Li, Hongchang, Jindong Li, Weiyan Liu, et al.. (2022). Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1α/miR-494/Survivin signaling pathway. Neoplasia. 32. 100821–100821. 37 indexed citations
9.
Liu, Jiazhe, et al.. (2021). Polyphyllin D induces apoptosis and protective autophagy in breast cancer cells through JNK1-Bcl-2 pathway. Journal of Ethnopharmacology. 282. 114591–114591. 34 indexed citations
10.
Li, Hongchang, Limin Liu, Junbin Ding, et al.. (2021). Astragalus IV Undermines Multi-Drug Resistance and Glycolysis of MDA-MB-231/ADR Cell Line by Depressing hsa_circ_0001982-miR-206/miR-613 Axis. Cancer Management and Research. Volume 13. 5821–5833. 12 indexed citations
11.
Liu, Jiazhe, Hongchang Li, Anwei Mao, et al.. (2020). DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation. Cell Cycle. 19(24). 3622–3631. 26 indexed citations
12.
Wang, Hongcheng, et al.. (2020). Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study. Scientific Reports. 10(1). 7048–7048. 58 indexed citations
13.
Liu, Jiazhe, Hongcheng Wang, Jianfa Wang, et al.. (2019). Total flavonoid aglycones extract in Radix Scutellariae induces cross-regulation between autophagy and apoptosis in pancreatic cancer cells. Journal of Ethnopharmacology. 235. 133–140. 30 indexed citations
14.
Liu, Yisong, Qi Tang, Pi Cheng, et al.. (2019). Whole-genome sequencing and analysis of the Chinese herbal plant Gelsemium elegans. Acta Pharmaceutica Sinica B. 10(2). 374–382. 35 indexed citations
15.
Liu, Jiazhe, Yang Qi, & Yi Tang. (2018). Mitigating the Harmonics of Parallel-Inverter Systems Considering Nonlinear Loads and Deadtime. 5. 5559–5564. 1 indexed citations
16.
Qi, Yang, Jingyang Fang, Jiazhe Liu, & Yi Tang. (2018). Coordinated control for harmonic mitigation of parallel voltage-source inverters. SHILAP Revista de lepidopterología. 2(3). 276–283. 19 indexed citations
17.
Sui, Fang, Jingjing Ma, Xinru Li, et al.. (2017). Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a. Endocrine. 56(1). 98–108. 18 indexed citations
18.
Liu, Wei, Fang Sui, Jiazhe Liu, et al.. (2016). PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer. Oncotarget. 7(34). 54744–54757. 13 indexed citations
19.
Wang, Na, Fang Sui, Jingjing Ma, et al.. (2016). Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer. Archives of Medical Research. 47(4). 285–292. 16 indexed citations
20.
Liu, Jiazhe, Qi Zheng, Jianzhong Di, et al.. (2014). Factors associated with mortality risk for malignant colonic obstruction in elderly patients. BMC Gastroenterology. 14(1). 76–76. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026